文献速递儿童青少年精神

1990至2021年全球204国20岁以下人群注意缺陷多动障碍的发病率、患病率与疾病负担

Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study.
PubMed 文献 · Mol Psychiatry · 2026-06-16

基于全球疾病负担研究2021数据,分析1990至2021年204个国家20岁以下人群ADHD的发病率、患病率和伤残调整生命年。2021年全球患病率为1.78%,发病率为0.16%,DALY率为每10万人21.8;患病率与发病率在澳大利亚最高,男性高于女性,且随社会人口指数升高而增加。

要点

  • 2021年全球20岁以下ADHD患病率为1.78%,发病率为0.16%。
  • 男性患病率2.52%高于女性0.99%,且随社会人口指数升高而增加。
  • 1990至2021年全球患病率和发病率分别小幅下降6.0%和5.81%。

核心结论

  • GBD 2021提供了全球20岁以下人群ADHD负担的最全面估计,但方法学局限可能低估患病率、发病率和负担。

研究设计与样本

  • 基于全球疾病负担研究2021的全球人口分析,评估1990至2021年204个国家和地区20岁以下人群的ADHD。

主要发现

  • 2021年全球20岁以下ADHD现患病例为46,890,733例(95%UI:32,136,904-67,271,064),新发病例为4,111,621例(2,775,203-5,954,941)。
  • ADHD导致574,979(294,277-977,557)个伤残调整生命年,全球DALY率为每10万人21.8(11.2-37.1)。
  • 患病率和发病率在澳大利亚最高,分别为5.62%(4.16-7.46%)和0.49%(0.34-0.66%)。
  • 1990至2021年全球患病率和发病率分别下降6.0%和5.81%;男性患病率2.52%高于女性0.99%,且随社会人口指数升高而增加。

临床怎么用

  • 全球ADHD负担估计可用于指导公共卫生政策与规划,但需注意可能被低估。

局限性

  • 原文指出潜在方法学局限可能导致ADHD的患病率、发病率和负担被低估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition in children and young people worldwide. Robust estimates of its incidence, prevalence, and burden are essential for informing public health policy and planning. Using data from the Global Burden of Disease Study 2021 (GBD 2021), this global population-based analysis assessed ADHD among individuals under 20 years of age across 204 countries and territories from 1990 to 2021. The study examined incidence, prevalence, and disability-adjusted life years (DALYs) associated with ADHD. In 2021, there were an estimated 46,890,733 (95% uncertainty interval [UI]: 32,136,904-67,271,064) prevalent cases and 4,111,621 (2,775,203-5,954,941) incident cases globally in individuals under 20 years. ADHD accounted for 574,979 (294,277-977,557) DALYs, with a global prevalence rate of 1.78% (1.22-2.55%) and an incidence rate of 0.16% (0.11-0.23%). The global DALY rate was 21.8 (11.2-37.1) per 100,000 population. Prevalence and incidence were highest in Australia, with rates of 5.62% (4.16-7.46%) and 0.49% (0.34-0.66%), respectively. Between 1990 and 2021, global prevalence and incidence rates decreased modestly by 6.0 and 5.81%, respectively. Across all GBD regions, prevalence was higher in males than females (2.52 vs 0.99%) and increased with higher socio-demographic index levels. Overall, the GBD 2021 study provides the most comprehensive global estimates of ADHD burden in young people. These findings are important for guiding policymakers and stakeholders, although potential methodological limitations suggest that the prevalence, incidence, and burden of ADHD may be underestimated.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cortese S, Kim MS, Han JH, et al. Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study. Mol Psychiatry. 2026. PMID: 42304068. doi:10.1038/s41380-026-03683-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。